REG3β contributes to the immunosuppressive microenvironment of pancreatic cancer

Emma Folch-Puy1

  • 1Experimental Pathology Department; IIBB-CSIC; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD); Barcelona, Spain.

Oncoimmunology
|December 20, 2013
PubMed

Insights

Levels of regenerating islet-derived 3β (REG3β) are elevated in pancreatic cancer patients. Silencing REG3β in a pancreatic cancer model inhibited tumor growth by altering macrophage polarization, suggesting a role for REG3β in cancer progression.

Area of Science:

  • Oncology
  • Immunology
  • Gastroenterology

Background:

  • Elevated levels of regenerating islet-derived 3β (REG3β) are observed in pancreatic ductal adenocarcinoma (PDAC) patients' serum and pancreatic juice.
  • The specific role of increased REG3β in PDAC oncogenesis and tumor progression remains largely unexamined.

Purpose of the Study:

  • To investigate the functional significance of REG3β in pancreatic cancer development and progression.
  • To determine the impact of REG3β modulation on tumor growth and the tumor microenvironment.

Main Methods:

  • Utilized a pancreatic cancer model to study the effects of gene silencing.
  • Assessed tumor growth and macrophage polarization following REG3β manipulation.

Main Results:

  • Silencing of REG3β in the pancreatic cancer model led to impaired tumor growth.
  • REG3β silencing was associated with a significant skewing of macrophage polarization.

Conclusions:

  • REG3β plays a role in promoting pancreatic cancer progression.
  • Modulating REG3β levels, potentially through targeting macrophage polarization, represents a therapeutic strategy for PDAC.